 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/19/2022 |
$0.65 |
$0.66 |
$0.62 |
$0.63 |
60.00K | | 09/20/2022 |
$0.62 |
$0.62 |
$0.58 |
$0.61 |
100.50K | | 09/21/2022 |
$0.60 |
$0.63 |
$0.59 |
$0.60 |
107.60K | | 09/22/2022 |
$0.59 |
$0.60 |
$0.56 |
$0.57 |
89.70K | | 09/23/2022 |
$0.57 |
$0.60 |
$0.55 |
$0.57 |
76.30K |
|
|
| AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen® is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon N Injection® is a natural alpha interferon for the intralesionaltreatment of refractory or recurring external genital warts in patients 18 years of age or older. | |
|
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on September 19, 2022, AIM opened at $0.65, traded as high as $0.66 and as low as $0.62, and closed at $0.63. Trading volume was a total of 60.00K shares. On September 20, 2022, AIM opened at $0.62, traded as high as $0.62 and as low as $0.58, and closed at $0.61. Trading volume was a total of 100.50K shares. On September 21, 2022, AIM opened at $0.60, traded as high as $0.63 and as low as $0.59, and closed at $0.60. Trading volume was a total of 107.60K shares. On September 22, 2022, AIM opened at $0.59, traded as high as $0.60 and as low as $0.56, and closed at $0.57. Trading volume was a total of 89.70K shares. On September 23, 2022, AIM opened at $0.57, traded as high as $0.60 and as low as $0.55, and closed at $0.57. Trading volume was a total of 76.30K shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/26/2012 |
|
| End date: |
09/23/2022 |
|
| Start price/share: |
$0.90 |
|
| End price/share: |
$0.57 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-36.67% |
|
| Average Annual Total Return: |
-4.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,330.71 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 09/19/2022 | $0.63 | | 09/20/2022 | $0.61 | | 09/21/2022 | $0.60 | | 09/22/2022 | $0.57 | | 09/23/2022 | $0.57 |
|
|
Free AIM Email Alerts:
